Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at AACR Annual Meeting|Apr. 5-10, 2024|Booth #2953

Recombinant Human ADM2

Cat.No. : ADM2-898H
Product Overview : Recombinant Human ADM2 full length or partial length protein was expressed.
  • Specification
  • Gene Information
  • Related Products
Source : Mammalian Cells
Species : Human
Tag : His
Form : Liquid or lyophilized powder
Endotoxin : < 1.0 eu per μg of the protein as determined by the LAL method.
Purity : >80%
Notes : This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications.
Storage : Store it at +4 oC for short term. For long term storage, store it at -20 oC~-80 oC.
Storage Buffer : PBS buffer
Gene Name : ADM2 adrenomedullin 2 [ Homo sapiens ]
Official Symbol : ADM2
Gene ID : 79924
mRNA Refseq : NM_001253845.1
Protein Refseq : NP_001240774.1
MIM : 608682
UniProt ID : Q7Z4H4

For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Inquiry

  • Q&As
  • Reviews

Q&As (9)

Ask a question
Are ADM2 agonists currently available for clinical use? 03/05/2022

ADM2 agonists are still in the experimental stage and are not yet available for clinical use. However, several drug candidates are currently being evaluated in preclinical studies and clinical trials, and may eventually be developed as new therapies for the treatment of pain and other disorders.

How are ADM2 proteins involved in the regulation of pain? 07/10/2021

ADM2 proteins have been implicated in the regulation of pain perception. ADM2 has been shown to decrease pain sensitivity in animal models of chronic pain, and ADM2 agonists may be potential treatments for chronic pain conditions.

Can ADM2 agonists be used to treat anxiety and depression? 01/27/2021

There is some evidence to suggest that ADM2 agonists may have therapeutic potential in the treatment of anxiety and depression. However, more research is needed to determine the safety and efficacy of ADM2 agonists for these conditions.

How are ADM2 proteins being studied for potential therapies for cardiovascular disease? 11/30/2020

ADM2 proteins are being studied for potential therapies for cardiovascular disease because of their vasodilatory and cardioprotective effects. ADM2 agonists, which mimic the activity of ADM2, are being developed as potential treatments for hypertension, heart failure, and other cardiovascular disorders.

How do ADM2 proteins interact with the immune system? 03/25/2020

ADM2 proteins can interact with the immune system in several ways. ADM2 has been shown to modulate the activity of immune cells, including T cells, B cells, and macrophages. ADM2 can promote the production of anti-inflammatory cytokines and inhibit the production of pro-inflammatory cytokines.

How are ADM2 agonists different from opioids as painkillers? 08/08/2019

Unlike opioids, ADM2 agonists do not bind to opioid receptors and therefore do not produce the same side effects associated with opioid use, such as addiction and respiratory depression. ADM2 agonists may offer a safer alternative for the management of chronic pain.

How might ADM2 agonists impact the opioid epidemic? 04/13/2019

ADM2 agonists could have a significant impact on the opioid epidemic by providing a safer alternative for pain management. Unlike opioids, ADM2 agonists do not produce the same addictive effects, respiratory depression, or risk of overdose. By providing a non-addictive alternative for pain management, ADM2 agonists could help reduce the number of people who become addicted to opioids. Additionally, ADM2 agonists could potentially be used to help people who are already addicted to opioids to manage their pain without increasing their risk of overdose or other adverse effects.

Are there any side effects associated with ADM2 agonists? 04/01/2017

There have been no reported side effects associated with ADM2 agonists in clinical trials to date. However, as with any new drug, long-term safety and efficacy will need to be established in larger clinical studies.

Can ADM2 proteins be used as a biomarker for sepsis? 07/03/2016

ADM2 proteins have been studied as a potential biomarker for sepsis, a life-threatening condition that occurs when the body's immune response to infection becomes dysregulated. ADM2 levels have been shown to be elevated in patients with sepsis, and may be useful for diagnosing and monitoring the condition.

Customer Reviews (4)

Write a review
Reviews
08/28/2019

    The manufacturer's attention to detail in the protein's production process is evident, and I am confident that this product will provide me with accurate and dependable data.

    06/17/2019

      the unparalleled technical support provided by the manufacturer has given me the confidence that any challenges I may encounter can be swiftly and effectively resolved.

      07/30/2018

        the purity and consistency of the ADM2 protein have exceeded my expectations, ensuring that my experiments will yield reliable and reproducible results.

        01/23/2017

          After conducting extensive research, I have determined that ADM2 protein is of exceptional quality and will undoubtedly meet all of my experimental requirements.

          Ask a Question for All ADM2 Products

          Required fields are marked with *

          My Review for All ADM2 Products

          Required fields are marked with *

          0

          Inquiry Basket

          cartIcon
          logo

          FOLLOW US

          Terms and Conditions        Privacy Policy

          Copyright © 2024 Creative BioMart. All Rights Reserved.

          Contact Us

          • /

          Stay Updated on the Latest Bioscience Trends